Melatonin protects against cardiac toxicity of doxorubicin in rat

Journal of Pineal Research

Volumn 31, Issue 4, 2001, Pages 301-307

  Xu, Mei Feng ^a   Ho, Susan ^a   Qian, Zhong Ming ^a   Tang, Pak Lai ^a  

^a HONG KONG POLYTECHNIC UNIVERSITY   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; DOXORUBICIN; MELATONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOTOXICITY; CONTROLLED STUDY; DOSE RESPONSE; HEART PROTECTION; HEMODYNAMICS; HISTOPATHOLOGY; IMMUNOMODULATION; LIPID PEROXIDATION; MALE; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; RAT;

ANIMALS; ANTINEOPLASTIC AGENTS; DOXORUBICIN; HEART; HEART DISEASES; HEMODYNAMIC PROCESSES; LIPID PEROXIDATION; MALE; MELATONIN; MYOCARDIUM; RATS; RATS, SPRAGUE-DAWLEY; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 0034754817     PISSN: 07423098     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-079X.2001.310403.x     Document Type: Article

References (40)

1. A randomized study of low-dose subcutaneous interleukin-2 plus melatonin versus supportive care alone in metastatic colorectal cancer patients progressing under 5-fluorouracil and folates
2. Nitrosation of melatonin by nitric oxide and peroxynitrite
3. Prevention of interleukin-2-induced thrombocytopenia during the immunotherapy of cancer by a concomitant administration of the pineal hormone melatonin
4. Protective effect of melatonin in carrageenan-induced models of local inflammation: Relationship to its inhibitory effect on nitric oxide production and its peroxynitrite scavenging activity
5. Cardiotoxicity from intensive chemotherapy combined with radiotherapy in breast cancer
6. Antioxidants protect against reactive oxygen species associated with adriamycin-treated cardiomyocytes
7. Doxorubicin toxicity in perfused rat heart. Decreased cell death at low oxygen tension
8. Review of tests for monitoring doxorubicin-induced cardiomyopathy
9. Influence of α-tocopherol on doxorubicin-induced lipid peroxidation, swelling and thiol depletion in rat heart mitochondria
10. Melatonin is a scavenger of peroxynitrite
11. Adriamycin depresses in vivo and in vitro phosphatidylethanolamine N-methylation in rat heart sarcolemma
12. Suppression of doxorubicin cardiotoxicity by overexpression of catalase in the heart of transgenic mice
13. Antioxidant agent nimesulid and β-blocker metoprolol do not exert protective effects against rat mitochondrial DNA alterations in adriamycin-induced cardiotoxicity
14. Selective inhibition of rat and human cardiac guanylate cyclase in vitro by doxorubicin (adriamycin): Possible link to anthracycline cardiotoxicity
15. Chemoneuroendocrine therapy of metastatic breast cancer with persistent thrombocytopenia with weekly low-dose epirubicin plus melatonin: A phase II study
16. Protein measurement with the folin phenol reagent
17. Doxorubicin-induced acute changes in cytotoxic aldehydes, antioxidant status and cardiac function in the rat
18. Enhancement of rat heart microsomal lipid peroxidation following doxorubicin treatment in vivo
19. Hyperlipidemic nephropathy induced by adriamycin: Effect of melatonin administration
20. Antioxidative effect of melatonin in rat brain oxidative stress induced by adriamycin
21. Melatonin, a pineal hormone with antioxidant property, protects against adriamycin cardiomyopathy in rats
22. Zinc accumulation in adriamycin-induced cardiomyopathy in rats: Effects of melatonin, a cardioprotective antioxidant
23. Adriamycin: The role of lipid peroxidation in cardiac toxicity and tumour response
24. Melatonin as biological response modifier in cancer patients
25. Melatonin and its precursors scavenge nitric oxide
26. Ambroxol inhibits doxorubicin-induced lipid peroxidation in heart of mice
27. Melatonin is an efficient antioxidant
28. Melatonin, hydroxyl radical-mediated oxidative damage, and aging: A hypothesis
29. Late cardiotoxicity after treatment for a malignant bone tumor
30. Superoxide dismutase does protect the cultured rat cardiac myocytes against hypoxia/reoxygenation injury
31. Antioxidant capacity of melatonin: A novel action not requiring a receptor
32. Pharmacological actions of melatonin in oxygen radical pathophysiology
33. Reversal of doxorubicin-induced cardiac metabolic damage by L-carnitine
34. Melatonin: A potent, endogenous hydroxyl radical scavenger
35. Differential behaviour of cell membranes towards iron-induced oxidative damage and the effect of melatonin
36. Lipid peroxidation and acute lung injury after thermal trauma to skin, evidence of a role for hydroxyl radical
37. Endothelial nitric oxide synthase-dependent superoxide generation from adriamycin
38. Phase I study of ICRF-187 using a daily for 3 days schedule
39. Effects by doxorubicin on the myocardium are mediated by oxygen free radicals
40. The protective role of manganese superoxide dismutase against adriamycin-induced acute cardiac toxicity in transgenic mice